Skip to content

CVS Health CVS Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

UnitedHealth Group logo
UnitedHealth GroupUNH
$231M-35.8%
LifeMD, Inc. logo
LifeMD, Inc.LFMD
$80.52K
Centene logo
CenteneCNC
$10M0.0%
Astrana Health logo
Astrana HealthASTH
$0-100%
Oscar Health logo
Oscar HealthOSCR
$1.14M-80.1%
Elevance Health logo
Elevance HealthELV

Other financials

Income statement

See full
Revenue$100.43B+6.2%
Gross profit$45.0B+3.3%
Operating income$4.7B+38.7%
Net income$2.9B+65.4%
EPS (diluted)$2.30+63.1%

Balance sheet

See full
Cash & equivalents$9.8B-5.6%
Total debt$15.2B-14.2%
Total equity$77.5B+0.7%
Total assets$252.97B-1.0%

Cash flow

See full
Operating cash flow$4.2B-6.7%
CapEx$849.0M+14.3%
Free cash flow$3.4B-10.8%

Valuation

See full
Market cap$131.99B+55.0%
Enterprise value$137.46B+48.8%
P/E45×+26.2×
P/S0.3×+0.1×

Profitability

See full
Gross margin44.7%-0.1pp
Operating margin1.5%-1.1pp
Net margin0.7%-0.7pp
FCF margin1.8%

Returns & leverage

See full
Return on equity3.8%-3.2pp
Debt / equity0.2×0.0×
Current ratio0.9×0.0×

Where this comes from

Reported directly by CVS Health in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.

The official record: CVS Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about CVS Health's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CVS Health's stock issuance proceeds?
CVS Health (CVS) reported stock issuance proceeds of $103M in Q1 2026.
How has CVS Health's stock issuance proceeds changed year-over-year?
CVS Health's stock issuance proceeds decreased by 28.5% year-over-year, from $144M to $103M.
What is the long-term trend for CVS Health's stock issuance proceeds?
Over 4 years (2021 to 2025), CVS Health's stock issuance proceeds has grown at a -8.0% compound annual growth rate (CAGR), from $549M to $394M.
What does stock issuance proceeds mean?
Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.